1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea has been researched along with Breast Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clavel, M; Dombernowsky, P; Howell, A; Pinedo, HM; Renard, J; Smyth, JF; van Glabekke, M | 1 |
Balslev, I; Ernst, P; Mouridsen, HT | 1 |
2 other study(ies) available for 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea and Breast Neoplasms
Article | Year |
---|---|
Phase II study of TCNU in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Female; Humans; Middle Aged; Nitrosourea Compounds; Taurine | 1988 |
Second-line chemotherapy with tauromustine in metastatic breast cancer in postmenopausal women: a phase II study.
Topics: Adult; Aged; Breast Neoplasms; Drug Evaluation; Female; Humans; Menopause; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Taurine | 1987 |